Staffan Encrantz
CIK: 0001870875
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Sight Sciences, Inc.
Discretionary Trading P&L
Holdings
Transaction History (18 total)
- Jun 10, 2026SGHT
Sight Sciences, Inc.
Purchase(P)Direct14.1K shares at avg. $4.88$69K - Jun 4, 2026SGHT
Sight Sciences, Inc.
Award(A)Direct28.3K shares- - Dec 16, 2025SGHT
Sight Sciences, Inc.
Purchase(P)Direct14K shares at avg. $8.31$116K - Jun 6, 2025SGHT
Sight Sciences, Inc.
Purchase(P)Direct27.9K shares at avg. $4.22$118K - Jun 5, 2025SGHT
Sight Sciences, Inc.
Award(A)Direct31K shares- - Jun 5, 2025SGHT
Sight Sciences, Inc.
Purchase(P)Direct41K shares at avg. $4.24$174K - Jun 4, 2025SGHT
Sight Sciences, Inc.
Purchase(P)Direct21.7K shares at avg. $4.17$90K - Jun 3, 2025SGHT
Sight Sciences, Inc.
Purchase(P)Direct25.2K shares at avg. $3.97$100K - Jun 2, 2025SGHT
Sight Sciences, Inc.
Purchase(P)Direct30.8K shares at avg. $3.88$119K - May 30, 2025SGHT
Sight Sciences, Inc.
Purchase(P)Direct42.8K shares at avg. $3.67$157K - May 29, 2025SGHT
Sight Sciences, Inc.
Purchase(P)Direct60.1K shares at avg. $3.59$216K - May 28, 2025SGHT
Sight Sciences, Inc.
Purchase(P)Direct26.7K shares at avg. $3.52$94K - May 27, 2025SGHT
Sight Sciences, Inc.
Purchase(P)Direct41.3K shares at avg. $3.44$142K - Mar 12, 2025SGHT
Sight Sciences, Inc.
Other(J)Indirect243K shares at avg. $2.77$673K - Mar 11, 2025SGHT
Sight Sciences, Inc.
Other(J)Indirect150K shares at avg. $2.71$407K - Mar 10, 2025SGHT
Sight Sciences, Inc.
Other(J)Indirect120K shares at avg. $2.53$304K - Nov 21, 2024SGHT
Sight Sciences, Inc.
Sale(S)Indirect551.8K shares at avg. $3.73$2.1M - Nov 21, 2024SGHT
Sight Sciences, Inc.
Purchase(P)Indirect551.8K shares at avg. $3.73$2.1M
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 10, 2026 | SGHT Sight Sciences, Inc. | Purchase(P) | 14,100 | $4.88 | $68,794 | Direct |
| Jun 4, 2026 | SGHT Sight Sciences, Inc. | Award(A) | 28,261 | - | $0 | Direct |
| Dec 16, 2025 | SGHT Sight Sciences, Inc. | Purchase(P) | 13,958 | $8.31 | $115,963 | Direct |
| Jun 6, 2025 | SGHT Sight Sciences, Inc. | Purchase(P) | 27,900 | $4.22 | $117,738 | Direct |
| Jun 5, 2025 | SGHT Sight Sciences, Inc. | Award(A) | 30,952 | - | - | Direct |
| Jun 5, 2025 | SGHT Sight Sciences, Inc. | Purchase(P) | 40,951 | $4.24 | $173,796 | Direct |
| Jun 4, 2025 | SGHT Sight Sciences, Inc. | Purchase(P) | 21,674 | $4.17 | $90,424 | Direct |
| Jun 3, 2025 | SGHT Sight Sciences, Inc. | Purchase(P) | 25,230 | $3.97 | $100,087 | Direct |
| Jun 2, 2025 | SGHT Sight Sciences, Inc. | Purchase(P) | 30,799 | $3.88 | $119,439 | Direct |
| May 30, 2025 | SGHT Sight Sciences, Inc. | Purchase(P) | 42,753 | $3.67 | $156,904 | Direct |
| May 29, 2025 | SGHT Sight Sciences, Inc. | Purchase(P) | 60,128 | $3.59 | $215,739 | Direct |
| May 28, 2025 | SGHT Sight Sciences, Inc. | Purchase(P) | 26,715 | $3.52 | $93,930 | Direct |
| May 27, 2025 | SGHT Sight Sciences, Inc. | Purchase(P) | 41,346 | $3.44 | $142,065 | Direct |
| Mar 12, 2025 | SGHT Sight Sciences, Inc. | Other(J) | 243,000 | $2.77 | $673,110 | Indirect |
| Mar 11, 2025 | SGHT Sight Sciences, Inc. | Other(J) | 150,000 | $2.71 | $406,500 | Indirect |
| Mar 10, 2025 | SGHT Sight Sciences, Inc. | Other(J) | 120,000 | $2.53 | $303,600 | Indirect |
| Nov 21, 2024 | SGHT Sight Sciences, Inc. | Sale(S) | 551,802 | $3.73 | $2,058,221 | Indirect |
| Nov 21, 2024 | SGHT Sight Sciences, Inc. | Purchase(P) | 551,802 | $3.73 | $2,058,221 | Indirect |
1-18 of 18 transactions
About Encrantz Staffan
Encrantz Staffan (SEC CIK 0001870875) files insider reports with the SEC as Director of Sight Sciences, Inc. (SGHT).
Signal8 holds 8 ownership filings by Encrantz Staffan, all Form 4s, filed between Nov 21, 2024 and Jun 11, 2026. Those filings report 18 transactions, from Nov 21, 2024 to Jun 10, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Encrantz Staffan's filings is in MENLO PARK, CA.
Recent filings by Encrantz Staffan
- Jun 10, 2026: Open-market purchase of SGHT shares (Form 4, code P).
- Jun 4, 2026: Grant or award of SGHT shares (Form 4, code A).
- Dec 16, 2025: Open-market purchase of SGHT shares (Form 4, code P).
- Jun 6, 2025: Open-market purchase of SGHT shares (Form 4, code P).
- Jun 5, 2025: Grant or award of SGHT shares (Form 4, code A).
Other insiders filing for Sight Sciences, Inc. (SGHT)
- Taylor Brenton, EVP, Operations & R&D
- Bauerlein Alison, Chief Operating Officer
- Rodberg James, Chief Financial Officer
- Badawi David, Chief Technology Officer
- Badawi Paul, President and CEO
- Rashid Kashif, Chief Legal Officer